+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Canada Hematological Disorders Market Outlook to 2036 - Hematology Tests and Hemostasis Tests

  • PDF Icon

    Report

  • 67 Pages
  • May 2026
  • Region: Canada
  • GlobalData
  • ID: 6108327

Canada Hematological Disorders Market Outlook to 2036 - Hematology Tests and Hemostasis Tests

Summary

The analyst’s “Canada Hematological Disorders Market Outlook to 2036” is a comprehensive databook report, covering key market data on the Canada Hematological Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Hematology Tests, Hemostasis Tests

The Canada Hematological Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Hematological Disorders Market.
  • Global corporate-level profiles of key companies operating within the Canada Hematological Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Canada Hematological Disorders is segmented as follows:

  • Hematology Tests
  • Hemostasis Tests

Reasons to Buy

The Canada Hematological Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Hematological Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hematological Disorders Market, Canada
2.1 Hematological Disorders Market, Canada, Revenue ($m), 2024-2036
2.1.1 Hematology Tests Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.2 Hemostasis Tests Market, Canada, Revenue ($m), by Segment, 2024-2036
2.2 Hematological Disorders Market, Canada, Volume (Units), 2024-2036
2.2.1 Hematology Tests Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.2 Hemostasis Tests Market, Canada, Volume (Units), by Segment, 2024-2036
2.3 Hematological Disorders Market, Canada, Average Price ($), 2024-2036
2.4 Hematological Disorders Market, Canada, Company Share by Revenue ($m), 2025
3 Hematological Disorders Market Pipeline Products
3.1 Hematological Disorders Market Pipeline Products
3.2 Hematological Disorders - Pipeline Products by Stage of Development
3.3 Hematological Disorders - Pipeline Products by Segment
3.4 Hematological Disorders - Pipeline Products by Territory
3.5 Hematological Disorders - Pipeline Products by Regulatory Path
3.6 Hematological Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Canada, Hematological Disorders Market
4.1 Sysmex Corp
4.1.1 Company Overview
4.2 Roche Diagnostics International Ltd
4.2.1 Company Overview
4.3 Beckman Coulter Inc
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 Siemens AG
4.5.1 Company Overview
4.6 Diagnostica Stago SAS
4.6.1 Company Overview
4.7 Thermo Fisher Scientific Inc
4.7.1 Company Overview
4.8 Instrumentation Laboratory Co
4.8.1 Company Overview
4.9 Siemens Healthineers AG
4.9.1 Company Overview
4.10 Radiometer Medical ApS
4.10.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.2 Government and Public Interest
5.2.1 Nov 13, 2025: Telo Genomics to Present Individual-Cell Risk Assessment MRD Technology at Myeloma Canada Summit
5.3 Other Significant Developments
5.3.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.4 Product News
5.4.1 Nov 13, 2025: Telo Genomics to Present Individual-Cell Risk Assessment MRD Technology at Myeloma Canada Summit
5.4.2 Oct 28, 2025: Arima Genomics Study Shows Aventa Lymphoma Test Resolves Diagnostic Ambiguity in B-Cell Lymphoma
5.4.3 Oct 09, 2025: American Society of Hematology Accepts Telo Genomics' Abstract for Presentation at 2025 Meeting
5.4.4 Oct 02, 2025: Hologic Receives FDA Clearance And CE Mark For Automated Molecular Tests To Detect Infectious Gastroenteritis
5.5 Strategy And Business Planning
5.5.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Hematological Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 2: Hematology Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 3: Hemostasis Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 4: Hematological Disorders Market, Canada, Volume (Units), 2024-2036
Table 5: Hematology Tests Market, Canada, Volume (Units), 2024-2036
Table 6: Hemostasis Tests Market, Canada, Volume (Units), 2024-2036
Table 7: Hematological Disorders Market, Canada, Average Price ($), 2024-2036
Table 8: Hematological Disorders Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Hematological Disorders Market Pipeline Products
Table 10: Hematological Disorders - Pipeline Products by Stage of Development
Table 11: Hematological Disorders Companies - Pipeline Products by Stage of Development
Table 12: Hematological Disorders - Pipeline Products by Segment
Table 13: Hematological Disorders - Pipeline Products by Territory
Table 14: Hematological Disorders - Pipeline Products by Regulatory Path
Table 15: Hematological Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hematological Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 2: Hematology Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hemostasis Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 4: Hematological Disorders Market, Canada, Volume (Units), 2024-2036
Figure 5: Hematology Tests Market, Canada, Volume (Units), 2024-2036
Figure 6: Hemostasis Tests Market, Canada, Volume (Units), 2024-2036
Figure 7: Hematological Disorders Market, Canada, Company Share (%), 2025
Figure 8: Hematological Disorders - Pipeline Products by Stage of Development
Figure 9: Hematological Disorders - Pipeline Products by Segment
Figure 10: Hematological Disorders - Pipeline Products by Territory
Figure 11: Hematological Disorders - Pipeline Products by Regulatory Path
Figure 12: Hematological Disorders - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sysmex Corp
  • Roche Diagnostics International Ltd
  • Beckman Coulter Inc
  • Abbott Laboratories
  • Siemens AG
  • Diagnostica Stago SAS
  • Thermo Fisher Scientific Inc
  • Instrumentation Laboratory Co
  • Siemens Healthineers AG
  • Radiometer Medical ApS